Bristol Myers Squibb
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Bristol Myers Squibb
Apr 30, 2024, 15:50 |
Blog
Hannah Wallace: Fork Cancer is a party with a purpose
Hannah Wallace, Director of Development at the American Cancer Society, shared on LinkedIn: "Last night…
Apr 26, 2024, 19:35 |
Blog
We are pleased to announce a worldwide capacity reservation and supply agreement with Cellares for the manufacture of CAR T cell therapies - Bristol Myers Squibb
Bristol Myers Squibb shared a post on LinkedIn: "We are pleased to announce a worldwide capacity…
Apr 26, 2024, 08:37 |
Blog
Karen Knudsen: A huge thank you to the 74 CEOs who participated in our one-day Fit2BeCancerFree CEO Challenge
Karen Knudsen shared on X/Twitter: ''A huge thank you to the 74 CEOs who participated in…
Apr 21, 2024, 11:45 |
Blog
Karen Knudsen: I’m pleased to share that the 2024 Fit2Be Cancer Free challenge is off to an incredible start!
Karen Knudsen shared a post on LinkedIn: “I’m pleased to share that the 2024 Fit2Be…
Apr 20, 2024, 06:35 |
Career
Sara Vergara: I’m happy to share that I’ve been promoted to Director of US Medical Affairs - Hematology (Myeloid) at Bristol Myers Squibb
Sara Vergara shared on LinkedIn: "I’m happy to share that I’ve been promoted to Director…
Apr 14, 2024, 02:34 |
Drugs
Joe Daccache: The realm of ADCs and their potential in oncology
Joe Daccache, Engagement Manager at DeciBio, shared a post on LinkedIn: "As we witness remarkable…
Apr 9, 2024, 15:56 |
Blog
We’ve been energized and inspired by our time at AACR2024 - Agenus
Agenus shared a post on LinkedIn: “We’ve been energized and inspired by our time at AACR2024.…
Apr 8, 2024, 16:54 |
Blog
Antonio Passaro: The phase 3 KRYSTAL-12 trial represents a significant advancement in our understanding and treatment of KRAS-mutated NSCLC
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn: "Why…
Apr 7, 2024, 07:08 |
Insight
Wafik El-Deiry: Clinical development portfolio at AACR24 by Michael Pourdehnad
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 6, 2024, 07:14 |
Drugs
Antonio Passaro: Why is this press release of Bristol Myers Squibb so crucial for our community?
Antonio Passaro, Medical Director at the Institute of European Oncology (IEO), shared a post on…
1
2
3
All:
22
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube